Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models
Open Access
- 18 December 2014
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 5870
Abstract
Close resemblance of murine and human trials is essential to achieve the best predictive value of animal-based translational cancer research. Kras-driven genetically engineered mouse models of non-small-cell lung cancer faithfully predict the response of human lung cancers to systemic chemotherapy. Owing to development of multifocal disease, however, these models have not been usable in studies of outcomes following focal radiotherapy (RT). We report the development of a preclinical platform to deliver state-of-the-art image-guided RT in these models. Presence of a single tumour as usually diagnosed in patients is modelled by confined injection of adenoviral Cre recombinase. Furthermore, three-dimensional conformal planning and state-of-the-art image-guided dose delivery are performed as in humans. We evaluate treatment efficacies of two different radiation regimens and find that Kras-driven tumours can temporarily be stabilized upon RT, whereas additional loss of either Lkb1 or p53 renders these lesions less responsive to RT.Keywords
This publication has 25 references indexed in Scilit:
- Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamicsThe Lancet Respiratory Medicine, 2013
- A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic responseNature, 2012
- An Orthotopic Lung Tumor Model for Image-Guided Microirradiation in RatsRadiation Research, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase InhibitorsPLOS ONE, 2007
- The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung CancerCancer Research, 2005
- Prospective study of palliative hypofractionated radiotherapy (8.5 Gy × 2) for patients with symptomatic non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Tumor Response to Radiotherapy Regulated by Endothelial Cell ApoptosisScience, 2003
- Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasGenes & Development, 2001